Victrex shares fall 15% to 15-year low on weak third-quarter update
Industrial end-demand solid Medical demand disappoints New chief executive arriving Considering how weak the stock has been over the past few years, investors in specialty chemicals firm Victrex (VCT) were probably expecting the market to take today's third-quarter trading update in its stride. Unfortunately, there isn't a lot of love out there for the business, and the shares dropped as much...